GeneDx Corp.

NASDAQ: WGSWW · Real-Time Price · USD
0.06
-0.00 (-3.85%)
At close: Jun 09, 2025, 3:38 PM

Company Description

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services.

The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights.

It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening.

GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

GeneDx Corp.
GeneDx  Corp. logo
Country United States
IPO Date n/a
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 1,000
CEO Katherine A. Stueland

Contact Details

Address:
North Tower
Stamford, Delaware
United States
Website https://www.genedx.com

Stock Details

Ticker Symbol WGSWW
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001818331
CUSIP Number n/a
ISIN Number US81663L1199
Employer ID 85-1966622
SIC Code 8000

Key Executives

Name Position
Katherine A. Stueland President, Chief Executive Officer & Director
Dr. Bryan M. Dechairo Ph.D. Chief Operating Officer
Heidi C. Chen J.D. Chief Legal Officer
Kevin Feeley CPA Chief Financial Officer
Dr. Martin G. Reese Ph.D. President of Fabric Genomics
Jami Biliboaca Head of People Strategy
Melanie Duquette Chief Growth Officer

Latest SEC Filings

Date Type Title
Jun 03, 2025 4 Filing
May 16, 2025 4 Filing
May 12, 2025 4 Filing
May 12, 2025 SCHEDULE 13G Filing
May 09, 2025 4/A [Amend] Filing
May 09, 2025 SCHEDULE 13G/A [Amend] Filing
May 07, 2025 SCHEDULE 13D/A [Amend] Filing
May 06, 2025 4 Filing
May 05, 2025 4 Filing
May 01, 2025 4 Filing